Formation and fate of platelet microparticles

Horstman, 1999, Platelet microparticles: a wide-angle perspective, Crit. Rev. Oncol./Hematol., 30, 111, 10.1016/S1040-8428(98)00044-4 Joop, 2001, Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms, Thromb. Haemost., 85, 810, 10.1055/s-0037-1615753 Berckmans, 2001, Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb. Haemost., 85, 639, 10.1055/s-0037-1615646 Castaman, 1996, A bleeding disorder characterised by isolated deficiency of platelet microvesicle generation, Lancet, 347, 700, 10.1016/S0140-6736(96)91259-3 Castaman, 1997, Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation, Br. J. Haematol., 96, 458, 10.1046/j.1365-2141.1997.d01-2072.x Hughes, 2000, Morphological analysis of microparticle generation in heparin-induced thrombocytopenia, Blood, 96, 188, 10.1182/blood.V96.1.188 Mallat, 2000, Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes, Circulation, 101, 841, 10.1161/01.CIR.101.8.841 Lee, 1993, Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias, Thromb. Res., 72, 295, 10.1016/0049-3848(93)90138-E Galli, 1996, Platelet-derived microvesicles in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, Thromb. Haemost., 75, 427, 10.1055/s-0038-1650291 Tomer, 2001, Thrombogenesis in sickle cell disease, J. Lab. Clin. Med., 137, 398, 10.1067/mlc.2001.115450 Ando, 2002, Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients, Kidney Int., 62, 1757, 10.1046/j.1523-1755.2002.00627.x Jy, 1992, Clinical significance of platelet microparticles in autoimmune thrombocytopenias, J. Lab. Clin. Med., 119, 334 Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x Basse, 1994, Correlation between inhibition of cytoskeleton proteolysis and anti-vesiculation effect of calpeptin during A23187-induced activation of human platelets: are vesicles shed by filopod fragmentation?, Biochim. Biophys. Acta, 1190, 217, 10.1016/0005-2736(94)90077-9 Fox, 1990, Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane, J. Cell Biol., 111, 483, 10.1083/jcb.111.2.483 Fox, 1991, Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets, J. Biol. Chem., 266, 13289, 10.1016/S0021-9258(18)98837-X Shcherbina, 1999, Moesin, the major ERM protein of lymphocytes and platelets, differs from ezrin in its insensitivity to calpain, FEBS Lett., 443, 31, 10.1016/S0014-5793(98)01674-3 Wiedmer, 1990, Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor, Biochemistry, 29, 623, 10.1021/bi00455a005 Pasquet, 1998, Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen, Biochem. J., 333, 591, 10.1042/bj3330591 Wiedmer, 1991, Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles, Blood, 78, 2880, 10.1182/blood.V78.11.2880.2880 Zhang, 2000, Mechanically gated channel activity in cytoskeleton-deficient plasma membrane blebs and vesicles from Xenopus oocytes, J. Physiol., 523, 117, 10.1111/j.1469-7793.2000.t01-1-00117.x Cunningham, 1995, Actin polymerization and intracellular solvent flow in cell surface blebbing, J. Cell Biol., 129, 1589, 10.1083/jcb.129.6.1589 Keller, 2002, Differences in cortical actin structure and dynamics document that different types of blebs are formed by distinct mechanisms, Exp. Cell Res., 277, 161, 10.1006/excr.2002.5552 Knowles, 1997, Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting, Proc. Natl. Acad. Sci. U. S. A., 94, 12969, 10.1073/pnas.94.24.12969 Raucher, 2000, Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion, Cell, 100, 221, 10.1016/S0092-8674(00)81560-3 Niebuhr, 2002, Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology, EMBO J., 21, 5069, 10.1093/emboj/cdf522 Hyvonen, 1995, Structure of the binding site for inositol phosphates in a PH domain, EMBO J., 14, 4676, 10.1002/j.1460-2075.1995.tb00149.x Fukami, 1992, Requirement of phosphatidylinositol 4,5-bisphosphate for alpha-actinin function, Nature, 359, 150, 10.1038/359150a0 Tsukita, 1999, Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins, J. Biol. Chem., 274, 34507, 10.1074/jbc.274.49.34507 MacDonald, 1993, Temperature and ionic effects on the interaction of erythroid spectrin with phosphatidylserine membranes, Biochemistry, 32, 6957, 10.1021/bi00078a021 O'Toole, 2000, Investigations of spectrin-lipid interactions using fluoresceinphosphatidylethanolamine as a membrane probe, Biochim. Biophys. Acta, 1466, 39, 10.1016/S0005-2736(00)00168-1 Niggli, 1994, Identification of functional domains in the cytoskeletal protein talin, Eur. J. Biochem., 224, 951, 10.1111/j.1432-1033.1994.00951.x Manno, 2002, Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability,, Proc. Natl. Acad. Sci. U. S. A., 99, 1943, 10.1073/pnas.042688399 O'Connell, 2005, Phosphatidylinositol 4,5-bisphosphate regulates activation-induced platelet microparticle formation, Biochemistry, 44, 6361, 10.1021/bi047344c Brogan, 2004, Endothelial and platelet microparticles in vasculitis of the young, Arthritis Rheum., 50, 927, 10.1002/art.20199 Serebruany, 2001, Uniform platelet activation exists before coronary stent implantation despite aspirin therapy, Am. Heart J., 142, 611, 10.1067/mhj.2001.116478 Cramer, 1997, Ultrastructure of platelet formation by human megakaryocytes cultured with the Mpl ligand, Blood, 89, 2336, 10.1182/blood.V89.7.2336 Rozmyslowicz, 2003, Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV, AIDS, 17, 33, 10.1097/00002030-200301030-00006 Bode, 1986, Analysis of platelet factor 3 in platelet concentrates stored for transfusion, Vox Sang., 51, 299, 10.1111/j.1423-0410.1986.tb01972.x Bode, 1991, Vesiculation of platelets during in vitro aging, Blood, 77, 887, 10.1182/blood.V77.4.887.887 Schlegel, 2001, Phosphatidylserine, a death knell, Cell Death Differ., 8, 551, 10.1038/sj.cdd.4400817 Pittoni, 2002, The clearance of apoptotic cells: implications for autoimmunity, Autoimmun. Rev., 1, 154, 10.1016/S1568-9972(02)00032-0 Ravichandran, 2003, “Recruitment signals” from apoptotic cells: invitation to a quiet meal, Cell, 113, 817, 10.1016/S0092-8674(03)00471-9 Brown, 2000, Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program, J. Biol. Chem., 275, 5987, 10.1074/jbc.275.8.5987 Savill, 1992, Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis, J. Clin. Invest., 90, 1513, 10.1172/JCI116019 Fourcade, 1995, Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells, Cell, 80, 919, 10.1016/0092-8674(95)90295-3 Atkinson, 1994, Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms, Clin. Exp. Immunol., 97, 1 Birmingham, 2001, CR1 and CR1-like: the primate immune adherence receptors, Immunol. Rev., 180, 100, 10.1034/j.1600-065X.2001.1800109.x Hess, 2003, Immune adherence revisited: novel players in an old game, News Physiol. Sci., 18, 104 Sahu, 2001, Structure and biology of complement protein C3, a connecting link between innate and acquired immunity, Immunol. Rev., 180, 35, 10.1034/j.1600-065X.2001.1800103.x Law, 1997, The internal thioester and the covalent binding properties of the complement proteins C3 and C4, Protein Sci., 6, 263, 10.1002/pro.5560060201 Sahu, 1994, Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation, Biochem. J., 302, 429, 10.1042/bj3020429 Sahu, 1995, Tyrosine is a potential site for covalent attachment of activated complement component C3, Mol. Immunol., 32, 711, 10.1016/0161-5890(95)98933-F